Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.08%69.86B | 15.64%268.23B | 25.05%65.86B | 23.17%231.95B | 25.62%59.61B | 22.18%59.74B | 24.47%59.94B | 20.19%52.66B | 22.80%188.32B | 30.25%47.45B |
| Cost of revenue | 8.08%16.76B | 15.26%64.29B | 21.99%15.5B | 16.65%55.78B | 19.42%14.16B | 15.12%14.61B | 15.87%14.31B | 16.31%12.71B | 25.24%47.82B | 28.90%11.85B |
| Gross profit | 5.47%53.11B | 15.76%203.94B | 26.02%50.35B | 25.39%176.17B | 27.68%45.45B | 24.64%45.13B | 27.44%45.63B | 21.48%39.96B | 21.99%140.5B | 30.71%35.6B |
| Operating expense | -2.79%44.97B | 15.39%187.2B | 28.51%46.26B | 24.14%162.23B | 26.17%43.32B | 20.25%41.37B | 22.46%41.55B | 28.45%36B | 35.09%130.69B | 40.77%34.34B |
| Selling and administrative expenses | 1.76%46.74B | 14.73%185.73B | 27.41%45.93B | 21.24%161.88B | 23.36%42.98B | 19.25%41.4B | 22.21%41.46B | 20.00%36.05B | 21.67%133.52B | 24.33%34.84B |
| -General and administrative expense | 1.76%46.74B | 14.73%185.73B | 27.41%45.93B | 21.24%161.88B | 23.36%42.98B | 19.25%41.4B | 22.21%41.46B | 20.00%36.05B | 21.67%133.52B | 24.33%34.84B |
| Other operating expenses | -20.32%396M | 133.15%2.98B | 360.19%497M | -52.54%1.28B | 109.39%580M | -29.44%163M | -71.81%428M | -83.86%108M | 8.19%2.7B | -51.15%277M |
| Total other operating income | 1,175.88%2.17B | 63.19%1.52B | 4.94%170M | -83.19%929M | -69.88%234M | -64.52%193M | -77.51%341M | -93.97%162M | -64.33%5.53B | -81.48%777M |
| Operating profit | 98.73%8.14B | 20.08%16.74B | 3.46%4.1B | 42.04%13.94B | 68.88%2.13B | 108.24%3.77B | 117.48%4.08B | -18.62%3.96B | -46.75%9.81B | -55.61%1.26B |
| Net non-operating interest income (expenses) | -328.32%-1.32B | -338.17%-1.96B | 5.27%579M | -424.64%-448M | 600.00%14M | 16.40%-683M | -221.48%-328M | -19.59%550M | 188.46%138M | -99.28%2M |
| Non-operating interest income | -84.49%203M | 6.94%1.85B | 51.33%1.31B | 40.19%1.73B | 192.31%874M | 71.13%332M | -40.00%321M | -8.95%865M | 20.74%1.23B | -50.17%299M |
| Non-operating interest expense | 108.90%1.53B | 75.07%3.81B | 131.75%730M | 98.72%2.18B | 189.56%860M | 0.40%1.02B | 144.91%649M | 18.42%315M | -6.96%1.1B | -7.76%297M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 109.52%6M | -253.33%-1.38B | -800.00%-63M | -419.67%-390M | -1,128.95%-391M | -119.23%-10M | -66.67%18M | 68.18%-7M | 180.79%122M | 240.74%38M |
| Special income (charges) | 84.78%-88M | -216.31%-8.07B | -1,276.19%-578M | -8.60%-2.55B | -23.57%-2.31B | 35.45%-142M | 31.82%-60M | 75.72%-42M | 43.94%-2.35B | 39.97%-1.87B |
| Less:Write off | -84.78%88M | 216.31%8.07B | 1,276.19%578M | 8.60%2.55B | 23.57%2.31B | -35.45%142M | -31.82%60M | -75.72%42M | -43.94%2.35B | -39.97%1.87B |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 66.98%6.74B | -49.46%5.33B | -9.55%4.03B | 36.56%10.55B | 1.95%-552M | 255.39%2.93B | 75.63%3.71B | -16.67%4.46B | -44.56%7.73B | -4,230.77%-563M |
| Income tax | -14.75%2.09B | -31.11%3.14B | 48.27%2.45B | 39.53%4.56B | 364.66%539M | 69.29%838M | 40.05%1.54B | 5.56%1.65B | -30.32%3.27B | 222.22%116M |
| Net income | 192.94%4.65B | -63.45%2.19B | -43.50%1.59B | 34.36%5.99B | -60.91%-1.09B | 534.55%2.09B | 114.07%2.18B | -25.84%2.81B | -51.78%4.46B | -1,283.67%-678M |
| Net income continuous operations | 192.94%4.65B | -63.45%2.19B | -43.50%1.59B | 34.36%5.99B | -60.91%-1.09B | 534.55%2.09B | 114.07%2.18B | -25.84%2.81B | -51.78%4.46B | -1,283.67%-678M |
| Noncontrolling interests | 245.95%256M | -40.53%314M | -54.04%74M | -15.92%528M | -87.00%13M | -9.15%129M | 1.81%225M | -3.01%161M | 139.69%628M | 7.53%100M |
| Net income attributable to the company | 190.35%4.39B | -65.67%1.87B | -42.84%1.51B | 42.64%5.46B | -41.72%-1.1B | 945.21%1.97B | 145.10%1.95B | -26.92%2.65B | -57.38%3.83B | -448.59%-779M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 190.35%4.39B | -65.67%1.87B | -42.84%1.51B | 42.64%5.46B | -41.72%-1.1B | 945.21%1.97B | 145.10%1.95B | -26.92%2.65B | -57.38%3.83B | -448.59%-779M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 201.97%49.04 | -70.88%16.95 | -44.57%16.24 | 47.07%58.21 | -37.14%-13.81 | 1,961.54%21.44 | 164.68%21.28 | -27.87%29.3 | -60.12%39.58 | -259.64%-10.07 |
| Diluted earnings per share | 202.49%48.67 | -70.83%16.81 | -44.65%16.09 | 46.72%57.63 | -37.14%-13.81 | 1,961.17%21.23 | 164.37%21.07 | -27.94%29.07 | -60.11%39.28 | -259.64%-10.07 |
| Dividend per share | 0 | 11.11%10 | 0 | 20.00%9 | 20.00%9 | 0 | 0 | 0 | 0.00%7.5 | 0.00%7.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |